| Ms Kristin M Schult, OTR | |
|
1525 W Frye Rd, Chandler, AZ 85224-6178 | |
| (480) 812-7000 | |
| Not Available |
| Full Name | Ms Kristin M Schult |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 1525 W Frye Rd, Chandler, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962530261 | NPI | - | NPPES |
| 847931 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | 3224 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Kristin M Schult, OTR 1525 W Frye Rd, Chandler, AZ 85224-6178 Ph: (480) 812-7000 | Ms Kristin M Schult, OTR 1525 W Frye Rd, Chandler, AZ 85224-6178 Ph: (480) 812-7000 |
News Archive
AstraZeneca today asked the U.S. Food and Drug Administration (FDA) to adopt guidance that will enable AstraZeneca and others to fully engage in real-time, social media conversations that responsibly provide accurate, balanced information on medicines from a known, identifiable and reliable source.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
The U.S. Food and Drug Administration today approved TOBI Podhaler (tobramycin inhalation powder) for the management of cystic fibrosis patients with Pseudomonas aeruginosa, a bacterium that causes lung infections.
High weight, little physical activity and smoking increase our vulnerability for severe bloodstream infections. They also increase mortality.
SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System, a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, announced the publication of one-year results from two separate prospective multicenter clinical trials as well as the publication of a systematic review of 18 MIS SI joint fusion studies.
› Verified 4 days ago
Sarah J. Whitney, MSOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 575 W Pecos Rd Apt 1127, Chandler, AZ 85225 Phone: 602-793-1492 | |
Taylor Knoll, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3160 N Arizona Ave Ste 105, Chandler, AZ 85225 Phone: 480-365-9981 | |
Kendra Alaine Bauman, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1525 W Frye Rd, Chandler, AZ 85224 Phone: 480-812-7000 | |
Mrs. Carole Beth Gates, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6283 W Megan St, Chandler, AZ 85226 Phone: 480-634-4993 | |
Kylie Metherd, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2715 S Alma School Rd Ste 3, Chandler, AZ 85286 Phone: 480-508-5252 | |
Christine Rose Prigge, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 621 N Tercera Ave, Chandler, AZ 85226 Phone: 480-239-1595 Fax: 480-855-3507 | |
Amy Carr, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2175 N Alma School Rd Ste A106, Chandler, AZ 85224 Phone: 480-855-0474 |